Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 Patients Via Indirect Inhibition of Transmembrane Protease, Serine 2 (TMPRSS2)
Clinical trial NCT04578236 · UNKNOWN
Trial details
- NCT number
- NCT04578236
- Sponsor
- Kafrelsheikh University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2020-12-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.